Primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adult: Sequential intensive treatment with the F-MACHOP regimen (±radiotherapy) and autologous bone marrow transplantation

Blood

Volumn 87, Issue 4, 1996, Pages 1243-1248

  Fanin, Renato ^a   Silvestri, Federico ^b   Geromin, Antonella ^b   Cerno, Michela ^b   Infanti, Laura ^b   Zaja, Francesco ^b   Barillari, Giovanni ^b   Savignano, Chiara ^b   Rinaldi, Cristina ^b   Damiani, Daniela ^b   Buffoli, Alberto ^b   Biffoni, Franco ^b   Baccarani, Michele ^b  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; ANAPLASTIC CARCINOMA; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; FEMALE; HUMAN; LARGE CELL LYMPHOMA; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTIGENS, CD30; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; FEMALE; FLUOROURACIL; HUMANS; LYMPHOMA, LARGE-CELL, KI-1; MALE; METHOTREXATE; PREDNISONE; TIME FACTORS; VINCRISTINE;

EID: 0030042743     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.4.1243.bloodjournal8741243     Document Type: Article

References (36)

1. Kadin ME: Primary Ki-1-positive anaplastic large-cell lymphoma: A distinct clinicopathologic entity. Ann Oncol 5:S25, 1994 (suppl 1)
2. Schwarting R, Stein H: Cluster report CD30, in Knapp W, Dörken B, Gilks WR, Rieber EP, Schmidt RE, Stein H, von de Borne AEGKr (eds): Leukocyte Typing IV. Oxford, UK, Oxford University Press, 1989, p 439
3. Schwab U, Stein H, Gerdes J, Lemke H, Kirchner H, Schaadt M, Diehl V: Production of a monoclonal antibody specific for Hodgkin's and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 299:65, 1982
4. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K: The expression of the Hodgkin's disease antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848, 1985
5. Stein H, Gerds J, Tippelmann G, Dienemann D, Schwarting R, O'Connor N, Pileri S, Pallesen G, Delsol G: Ki-1 lymphoma: Experimental and clinical findings. Third International Conference on Malignant Lymphoma, Lugano, Switzerland, June 10-13, 1987 (abstr)
6. Stansfeld AG, Diebold J, Kapanci Y, Kelenyi G, Lannert K, Mioduszewska O, Noel H, Rilke F, Sundstrom C, Van Unnik JAM, Wright HD: Updated Kiel classification for lymphomas. Lancet 1:292, 1988
7. Agnarsson BN, Kadin EK: Ki-1 positive large cell lymphoma. Am J Surg Pathol 12:264, 1988
8. Rodriguez J, Pugh W, Romaguera J, Cabanillas F: Anaplastic Ki-1+ large-cell lymphoma. Cancer Invest 11:554, 1993
9. Chan JKC, Ng CS, Hui PK, Leung TW, Lo ESF, Lau WH, McGuire LJ: Anaplastic large cell Ki-1 lymphoma. Delineation of two morphological types. Histopathology 15:11, 1989
10. Tashiro K, Kikuchi M, Takeshita M, Yoshida T, Ohshima K: Clinicopathological study of Ki-1-positive lymphomas. Pathol Res Pract 185:461, 1989
11. Chott A, Kaserer K, Augustin I, Vesely M, Heinz R, Oehlinger W, Hanak H, Radaszkiewcz T: Ki-1 positive large cell lymphoma. A clinicopathologic study of 41 cases. Am J Surg Pathol 14:439, 1990
12. Nakamura S, Takagi N, Kojima M, Motoori T, Kitoh K, Osada H, Suzuki H, Ogura M, Kurita S, Oyama A, Ueda R, Takahashi T, Sucht T: Clinicopathologic study of large cell anaplastic lymphoma (Ki-1-positive large cell lymphoma) among the Japanese. Cancer 68:118, 1991
13. Penny RJ, Blaustein JC, Longtine JA, Pinkus GS: Ki-1-positive large cell lymphomas, a heterogenous group of neoplasms. Cancer 68:362, 1991
14. Greer JP, Kinney MC, Collins RD, Salhany KE, Wolff SN, Hainsworth JD, Flexner JM, Stein RS: Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma J Clin Oncol 9:539, 1991
15. de Bruin PC, Beljaards RC, van Heerde P, Van Der Valk P, Noorduyn LA, Van Krieken JH, Kluin-Nelemans JC, Willemze R, Meijer CJ: Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. Histopathology 23:127, 1993
16. Shulman LN, Frisard B, Antin JH, Wheeler C, Pinkus G, Magauran N, Mauch P, Nobles E, Mashal R, Canellos G, Tung N, Kadin M: Primary Ki-1 anaplastic large-cell lymphoma in adults: Clinical characteristics and therapeutic outcome. J Clin Oncol 11:937, 1993
17. Pileri S, Bocchia M, Baroni CD, Martelli M, Falini B, Sabattini E, Gherlinzoni F, Amadori S, Poggi S, Mazza P, Burgio V, Zinzani PL, Melilli G, Benni M, Saragoni L, Martelli M, Stein H, Mandelli F, Tura S: Anaplastic large cell lymphoma (CD30+/Ki-1+): Results of a prospective clinico-pathological study of 69 cases. Br J Haematol 86:513, 1994
18. Romaguera JE, Manning JT Jr, Tornos CS, Rodriguez J, Brooks TE, Pugh WB, Ordonez NG, Goodacre AM, Cabanillas F: Long-term prognostic importance of primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large-cell lymphoma. Ann Oncol 5:317, 1994
19. Tirelli U, Vaccher E, Zagonel V, Talamini R, Bernardi D, Tavia M, Gloghini A, Merola MC, Monfardini S, Carbone A: CD30 (Ki-1)-positive anaplastic large-cell lymphomas in 13 patients with and 27 patients without human immunodeficiency virus infection: The first comparative clinicopathologic study from a single institution that also includes 80 patients with other human immunodeficiency virus-related systemic lymphomas. J Clin Oncol 13:373, 1995
20. Bitter MA, Franklin WA, Larson RA, McKeithan TW, Rubin CM, Le Beau MM, Stephens JK, Vardiman JW: Morphology in Ki-1 (CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am J Surg Pathol 14:305, 1990
21. Salhany KE, Collins RD, Greer JP, Kinney MC: Long-term survival in Ki-1 lymphoma. Cancer 67:516, 1991
22. Marosi C, Heinz R, Steger G, Fortelny A, Chott A, Hanak H, Radaszkiewicz T, Baur M, Kreiner G, Schwarzinger I: MACOP-B treatment in patients with Ki-1-positive large-cell anaplastic lymphoma. J Cancer Res Clin Oncol 118:314, 1992
23. Harris NL, Jaffe ES, Stein H, Banks PM, Chan KC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
24. Stein H, Herbst H, Anagnostopoulos I, Niedobitek G, Dallenbach F, Kratzsch HC: The nature of Hodgkin and Reed-Sternberg cells, their association with EBV, and their relationship to anaplastic large cell lymphoma. Ann Oncol 2:33, 1991
25. Pileri S, Mazza P, Zinzani PL, Poggi S, Poletti G, Falini B, Tura S: Ki-1 lymphoma and Hodgkin's disease. Haematologica 74:333, 1989
26. Kaudewitz P, Stein H, Dallenbach F, Eckert F, Bieber K, Burg G, Braun-Falco O: Primary and secondary cutaneous Ki-1+ (CD30) anaplastic large cell lymphomas. Am J Pathol 135:359, 1989
27. Beljaards RC, Kaudewitz P, Berti E, Gianotti R, Neumann C, Rosso R, Paulli M, Meijer CJ, Willemze R: Primary cutaneous CD30-positive large cell lymphoma: Definition of a new type of cutaneous lymphoma with a favourable prognosis. A European mullicenter study of 47 patients. Cancer 71:2097, 1993
28. De Vita F, Di Grazia M, Orditura M, Saieva MR, Catalano G: Autologous bone marrow transplantation in Ki-1 lymphoma with poor prognosis. A case report. Recenti Prog Med 85:278, 1994
29. Guglielmi C, Amadori S, Anselmo AP, Baroni CD, Biagini C, Cimino G, Papa G, Mandelli F: Sequential combination chemotherapy of high-grade non-Hodgkin's lymphoma with 5-fluorouracil, methotrexate, cytosine-arabinoside, cyclophosphamide, doxorubicin, vincristine, and prednisone (F-MACHOP). Cancer Invest 5:159, 1987
30. Guglielmi C, Amadori S, Martelli M, Dragoni F, Mandelli F: The F-MACHOP sequential combination chemotherapy regimen in advanced diffuse aggressive lymphomas: Long-term results. Ann Oncol 2:365, 1991
31. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M: Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31:860, 1971
32. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649, 1982
33. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's Lymphoma. N Engl J Med 329:987, 1993
34. Reiter A, Schrappe M, Tiemann M, Parwaresch R, Zimmermann M, Yakisan E, Dopfer R, Bucsky P, Mann G, Gadner H, Riehm H: Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: A prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. J Clin Oncol 12:899, 1994
35. Sandlund JT, Pui CH, Santana VM, Mahmoud H, Roberts WM, Morris S, Raimondi S, Ribeiro R, Crist WM, Lin JS, Mao I, Berard CW, Hutchison E: Clinical features and treatment outcome for children with CD30+ large-cell non-Hodgkin's lymphoma. J Clin Oncol 12:895, 1994
36. Fraga M, Brousset P, Schlaifer D, Payen C, Robert A, Rubie H, Huguet-Rigal F, Delsol G: Bone marrow involvement in anaplastic large cell lymphoma. Am J Clin Pathol 103:82, 1995